Substance / Medication

Tegaserod maleate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Tegaserod maleate in the treatment of irritable bowel syndrome: a clinical review.
Rivkin Anastasia · Clin Ther · 2003
PMID: 12946544Review
Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy.
Li Xiao, Wu Liangliang, Zheng Zhiying et al. · J Oncol · 2022
PMID: 35154317OtherFull text (PMC)
Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2.
Wang Zitong, Chen Yingying, Li Xiaoyu et al. · Cancers (Basel) · 2022
PMID: 35892850OtherFull text (PMC)
Tegaserod maleate exhibits antileukemic activity by targeting TRPM8.
Xie Xiaoling, Yang Wanwen, Zhang Wuju et al. · Biomed Pharmacother · 2022
PMID: 35994820Other
Estimation of tegaserod maleate by differential pulse polarography.
Rajput S J, Raj H A · Indian J Pharm Sci · 2009
PMID: 20177456OtherFull text (PMC)
In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
Zhang Shuang-Qing, Thumma Sridhar, Chen Guo-Hua et al. · Eur J Pharm Biopharm · 2008
PMID: 18037278Other
Tegaserod maleate (Zelnorm) for IBS with constipation.
Med Lett Drugs Ther · 2002
PMID: 12237618Other
Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway.
Cai Maoping, Ge Shengdong, Hong Yaying et al. · Mol Med · 2025
PMID: 39881254PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tegaserod maleate (substance)
SNOMED CT
386035006
UMLS CUI
C1137921

Clinical Data

This intervention maps to 6 entities in the Ltrl knowledge graph.

1
Conditions
2
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.